Abstract
Extrapyramidal symptoms (EPS) refer to movement disorders that result from lesions in the basal ganglia and its connections, due to interference with dopaminergic transmission. Antipsychotics are a common cause of EPS.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951–62.
Dayalu P, Chou KL. Antipsychotic-induced extrapyramidal symptoms and their management. Expert Opin Pharmacother. 2008;9(9):1451–62.
Kane JM, Fleischhacker WW, Hansen L, Perlis R, Pikalov III A, Assuncao-Talbott S. Akathisia: an updated review focusing on second-generation antipsychotics. J Clin Psychiatry. 2009;70(5):627–43.
Kane JM, Smith JM. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry. 1982;39(4):473–81.
Correll CU, Schenk EM. Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatry. 2008;21(2):151–6.
Smith JM, Baldessarini RJ. Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch Gen Psychiatry. 1980;37(12):1368–73.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Annamalai, A. (2017). Extrapyramidal Symptoms II (Dystonia, Akathisia, Tardive Dyskinesia). In: Medical Management of Psychotropic Side Effects. Springer, Cham. https://doi.org/10.1007/978-3-319-51026-2_37
Download citation
DOI: https://doi.org/10.1007/978-3-319-51026-2_37
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-51024-8
Online ISBN: 978-3-319-51026-2
eBook Packages: MedicineMedicine (R0)